XML 29 R16.htm IDEA: XBRL DOCUMENT v3.25.1
Note 11 - Segments and Geographic Information
3 Months Ended
Mar. 31, 2025
Notes to Financial Statements  
Revenue from Contract with Customer [Text Block]

11. Segment and Geographic Information

 

The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company’s oral and IV TPOXX® as well as research and development services. The Company derives revenue primarily from sales to the U.S. Government as well as international governments (including government affiliated entities) and manages the business activities on a consolidated basis. The segment derives revenues from customers through the delivery of product and fulfillment of research and development services.

 

The Chief Operating Decision Maker ("CODM") assesses performance for the segment and decides how to allocate resources based on net income that also is reported on the income statement as consolidated net income. Consolidated net income is also a measure that is considered in monitoring budget versus actual results.

 

The CODM does not review assets in evaluating the results of the segment, and therefore, such information is not presented.

 

The following table provides the operating result of the Company's segment:

 

  

Three Months Ended March 31,

 
  

2025

  

2024

 

Revenue

        

Product sales and supportive services

 $5,821,247  $23,878,677 

Research and development

  1,219,568   1,551,178 

Total revenues

 $7,040,815   25,429,855 

Less:

        

Cost of sales and supportive services

  157,738   3,225,314 

Employee expenses

  4,170,921   4,702,132 

R&D vendor expenses

  547,969   605,442 

Professional fee expenses

  1,288,644   1,266,761 

International promotion fees

     1,526,811 

Other segment items (1)

  3,153,681   2,841,626 

Interest income

  (1,707,723)  (1,956,067)

(Benefit)/Provision for income taxes

  (162,192)  2,940,496 

Net (loss)/income

 $(408,223) $10,277,340 

 

(1) Other segment items include insurance, regulatory and consultant expenses, as well as various general corporate costs.

 

Revenues by geographic region were as follows:

 

  

Three Months Ended March 31,

 
  

2025

  

2024

 

United States

 $1,219,568  $17,450,199 
         

International

        

Canada

  5,821,247   737,677 

Europe, Middle East and Africa (EMEA)

     7,241,979 

Total International

  5,821,247   7,979,656 
         

Total revenues

 $7,040,815  $25,429,855